Clinical Trial Details
| Trial ID: | L1885 |
| Source ID: | NCT05479591 |
| Associated Drug: | Ideglira |
| Title: | A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia |
| Acronym: | GLIDE |
| Status: | WITHDRAWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: IDegLira |
| Outcome Measures: | Primary: Change in Glycated Haemoglobin A1c (HbA1c), Measured in percentage (%) point., From baseline to end of study (week 36 ± 6 weeks) | Secondary: Number of participants with HbA1c less than (<) 7.0%, Number of participants having Yes/No., At end of study (week 36 ± 6 weeks)|Starting dose of IDegLira, Measured in dose steps/day., At baseline|Dose of IDegLira at end of study, Measured in dose steps/day., At end of study (week 36 ± 6 weeks)|Change in body weight, Measured in kilograms (kg)., From baseline to end of study (week 36 ± 6 weeks) |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 0 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2022-07-30 |
| Completion Date: | 2023-04-30 |
| Results First Posted: | |
| Last Update Posted: | 2022-11-01 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT05479591 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|